SEMNUR PHARMACEUTICALS INC (SMNR) Institutional Ownership Changes & 13F Activity

SEMNUR PHARMACEUTICALS INC (SMNR). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q3 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Transce3Nd, Llc, Gamma Investing Llc, and Rhumbline Advisers.

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Transce3Nd, LlcBuy+500—500$188.00Q3 2026Oct 26, 2026
Gamma Investing LlcSell-102-87.9%14$8.00Q3 2026Oct 08, 2026
Rhumbline AdvisersSell-30-100.0%0$0.00Q3 2026Aug 12, 2026
Showing 3 of 3

Frequently asked questions about SMNR activity

  • Which institutional owners are buying SMNR?

    Institutional owners buying SMNR include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in SMNR activity?

    "Buy" means an investor increased their reported position in SMNR compared to the prior reporting period. This reflects growing exposure to SEMNUR PHARMACEUTICALS INC (SMNR) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in SMNR increasing?

    Institutional interest in SMNR can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related SMNR Institutional Insights